Canonical: https://neurodiversity.gklijs.tech/i/6671eaa0c07d

# Methylphenidate Improves Objective QbTest Performance in Adults With ADHD and Polysubstance Use

Bioengineer.org

13 November 2026 (2026-11-13)

A single 20-milligram dose of immediate-release methylphenidate significantly improved objective measures of attention, motor activity, and impulse control in adults with untreated ADHD and long-term polysubstance use, as demonstrated by the QbTest assessment. These improvements were statistically significant compared to baseline and placebo, with placebo effects limited primarily to subjective perceptions and response speed. The study highlights methylphenidate's potential as an effective treatment for ADHD in individuals with concurrent polysubstance use.

[Read at Bioengineer.org](<https://bioengineer.org/methylphenidate-improves-objective-qbtest-performance-in-adults-with-adhd-and-polysubstance-use/>)

All articles from [13 November 2026](</2026/11/13>). Summaries are AI-generated and may contain errors; the linked article is the authority.

## Get this news by email

Daily or as a weekly roundup in your inbox. You confirm your address first; every email has an unsubscribe link. For another topic or language, use the [subscribe page](</subscribe>).

## More to read

- [Topics](</topics>)
- [Agenda](</agenda>)
- [Subscribe](</subscribe>)
